Literature DB >> 11031234

Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host.

D L Goosney1, S Gruenheid, B B Finlay.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a gram-negative bacterial pathogen that adheres to human intestinal epithelial cells, resulting in watery, persistent diarrhea. It subverts the host cell cytoskeleton, causing a rearrangement of cytoskeletal components into a characteristic pedestal structure underneath adherent bacteria. In contrast to other intracellular pathogens that affect the actin cytoskeleton from inside the host cytoplasm, EPEC remains extracellular and transmits signals through the host cell plasma membrane via direct injection of virulence factors by a "molecular syringe," the bacterial type III secretion system. One injected factor is Tir, which functions as the plasma membrane receptor for EPEC adherence. Tir directly links extracellular EPEC through the epithelial membrane and firmly anchors it to the host cell actin cytoskeleton, thereby initiating pedestal formation. In addition to stimulating actin nucleation and polymerization in the host cell, EPEC activates several other signaling pathways that lead to tight junction disruption, inhibition of phagocytosis, altered ion secretion, and immune responses. This review summarizes recent developments in our understanding of EPEC pathogenesis and discusses similarities and differences between EPEC pedestals, focal contacts, and Listeria monocytogenes actin tails.

Entities:  

Mesh:

Year:  2000        PMID: 11031234     DOI: 10.1146/annurev.cellbio.16.1.173

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  41 in total

1.  Actin pedestal formation by enteropathogenic Escherichia coli and intracellular motility of Shigella flexneri are abolished in N-WASP-defective cells.

Authors:  S Lommel; S Benesch; K Rottner; T Franz; J Wehland; R Kühn
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

Review 2.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 3.  Enteropathogenic Escherichia coli: foe or innocent bystander?

Authors:  J Hu; A G Torres
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

4.  Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation.

Authors:  Yu Wang; Guang-Sheng Xiang; Famourou Kourouma; Shahid Umar
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

5.  Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection.

Authors:  Laura Q Leverton; James B Kaper
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Expression of putative virulence factors of Escherichia coli O157:H7 differs in bovine and human infections.

Authors:  Rebecca A Rashid; Tami A Tabata; Melissa J Oatley; Thomas E Besser; Phillip I Tarr; Steve L Moseley
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Lymphocytic colitis: a clue to bacterial etiology.

Authors:  Thanaa Ea Helal; Naglaa S Ahmed; Osama Abo El Fotoh
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

8.  Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli.

Authors:  Ravinder K Gill; Alip Borthakur; Kim Hodges; Jerrold R Turner; Daniel R Clayburgh; Seema Saksena; Ayesha Zaheer; Krishnamurthy Ramaswamy; Gail Hecht; Pradeep K Dudeja
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 10.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.